FF
ABBV icon

Fluent Financial’s AbbVie ABBV Stock Holding History

Fluent Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,161
Closed -$4.29M – 60
2024
Q4 		$4.29M Buy
24,161
+2,307
+11% +$424K 1.9% 16
2024
Q3 		$4.32M Sell
21,854
-3,296
-13% -$615K 2.08% 16
2024
Q2 		$4.31M Buy
25,150
+2,570
+11% +$426K 2.18% 15
2024
Q1 		$4.11M Sell
22,580
-2,977
-12% -$513K 2.27% 11
2023
Q4 		$3.96M Sell
25,557
-911
-3% -$133K 2.35% 15
2023
Q3 		$3.95M Buy
+26,468
New +$3.89M 2.12% 17

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Fluent Financial's ABBV Position: Q1 2025 in Review

Fluent Financial sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 24,161 shares — an estimated $4.29M sold.

Fluent Financial first reported a position in ABBV in Q3 2023 and held it in 6 quarters. The position peaked at $4.32M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Fluent Financial reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Fluent Financial sold 24,161 AbbVie shares in Q1 2025, an estimated $4.29M.
  • Fluent Financial first reported a position in AbbVie in Q3 2023 and held it in 6 quarters.
  • Fluent Financial's AbbVie position peaked at $4.32M in Q3 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Fluent Financial's 13F filing for Q1 2025, filed 10 Apr 2025.